Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Primary Peritoneal Cancers and Secondary Peritoneal Cancers From Stomach, Colorectal, Appendiceal, and/or Gynecological Origins

NCT03604653 is registered in ClinicalTrials.gov with Holy Name Medical Center, Inc. as lead sponsor.

NCT NCT03604653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03604653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Primary Peritoneal Cancers and Secondary Peritoneal Cancers From Stomach, Colorectal, Appendiceal, and/or Gynecological Origins
Lead sponsor
Holy Name Medical Center, Inc.
Phase
Observational
Overall status
Completed
Start date
May 15, 2018
Completion date
May 1, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appendiceal cancer, cervical cancer, colorectal cancer, fallopian tube cancer, ovarian cancer, primary peritoneal carcinoma, stomach cancer, uterine cancer